Dr. David Horna is the CEO and Co-Founder of Aglaris, a biotechnology company revolutionizing the manufacturing of cell and gene therapies through automation, AI integration, and advanced bioprocessing platforms. With a background in Chemical Engineering and Biomedical science and over 15 years of experience across biotech innovation, clinical research, and advanced therapy development, David brings a unique combination of technical insight and strategic leadership. Under his direction, Aglaris has developed the FACER system, a next-generation closed bioreactor designed to automate and simplify complex cell therapy processes, significantly improving scalability and reducing production costs. David is a strong advocate for decentralized manufacturing and is actively involved in shaping the future of CGT infrastructure across Europe.